Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 379

1.

Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004.

Herrera GA, Iwane MK, Cortese M, Brown C, Gershman K, Shupe A, Averhoff F, Chaves SS, Gargiullo P, Bridges CB.

Vaccine. 2007 Jan 2;25(1):154-60. Epub 2006 Aug 2. Erratum in: Vaccine. 2008 Jul 29;26(32):4101-3.

PMID:
17064823
2.

Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2008 Apr 18;57(15):393-8.

3.

Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.

Belongia EA, Kieke BA, Donahue JG, Greenlee RT, Balish A, Foust A, Lindstrom S, Shay DK; Marshfield Influenza Study Group.

J Infect Dis. 2009 Jan 15;199(2):159-67. doi: 10.1086/595861.

PMID:
19086915
4.

Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons: a case-cohort study.

Szilagyi PG, Fairbrother G, Griffin MR, Hornung RW, Donauer S, Morrow A, Altaye M, Zhu Y, Ambrose S, Edwards KM, Poehling KA, Lofthus G, Holloway M, Finelli L, Iwane M, Staat MA; New Vaccine Surveillance Network.

Arch Pediatr Adolesc Med. 2008 Oct;162(10):943-51. doi: 10.1001/archpedi.162.10.943.

PMID:
18838647
5.

Assessment of the effectiveness of the 2003-04 influenza vaccine among children and adults--Colorado, 2003.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2004 Aug 13;53(31):707-10.

6.

Preliminary assessment of the effectiveness of the 2003-04 inactivated influenza vaccine--Colorado, December 2003.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2004 Jan 16;53(1):8-11.

7.

Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.

Skowronski DM, Masaro C, Kwindt TL, Mak A, Petric M, Li Y, Sebastian R, Chong M, Tam T, De Serres G.

Vaccine. 2007 Apr 12;25(15):2842-51. Epub 2006 Oct 16.

PMID:
17081662
8.

A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.

Skowronski DM, Janjua NZ, De Serres G, Winter AL, Dickinson JA, Gardy JL, Gubbay J, Fonseca K, Charest H, Crowcroft NS, Fradet MD, Bastien N, Li Y, Krajden M, Sabaiduc S, Petric M.

Clin Infect Dis. 2012 Aug;55(3):332-42. doi: 10.1093/cid/cis431. Epub 2012 Apr 26.

PMID:
22539661
9.

[Efficiency of seasonal influenza vaccine in persons older than 65 in Romania. Pilot case-control study I-MOVE, 2008-2009].

Piţigoi D, Lupulescu E, Alexandrescu V, Băeţel A, Sbârcea C, Ioniţă E, Săvulescu C, Duca E, Sima C, Truică C, Ibram S, Bobîrnac A, Militaru L, Arion M.

Bacteriol Virusol Parazitol Epidemiol. 2009 Apr-Jun;54(2):109-16. Romanian.

PMID:
20422925
10.

Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study.

Kissling E, Valenciano M, Larrauri A, Oroszi B, Cohen JM, Nunes B, Pitigoi D, Rizzo C, Rebolledo J, Paradowska-Stankiewicz I, Jiménez-Jorge S, Horváth JK, Daviaud I, Guiomar R, Necula G, Bella A, O'Donnell J, Głuchowska M, Ciancio BC, Nicoll A, Moren A.

Euro Surveill. 2013 Jan 31;18(5). pii: 20390.

11.

Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results.

Andrews N, McMenamin J, Durnall H, Ellis J, Lackenby A, Robertson C, von Wissmann B, Cottrell S, Smyth B, Moore C, Gunson R, Zambon M, Fleming D, Pebody R.

Euro Surveill. 2014 Jul 10;19(27):5-13.

12.

Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.

Skowronski DM, De Serres G, Dickinson J, Petric M, Mak A, Fonseca K, Kwindt TL, Chan T, Bastien N, Charest H, Li Y.

J Infect Dis. 2009 Jan 15;199(2):168-79. doi: 10.1086/595862.

PMID:
19086914
13.

Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses.

Skowronski DM, Janjua NZ, De Serres G, Sabaiduc S, Eshaghi A, Dickinson JA, Fonseca K, Winter AL, Gubbay JB, Krajden M, Petric M, Charest H, Bastien N, Kwindt TL, Mahmud SM, Van Caeseele P, Li Y.

PLoS One. 2014 Mar 25;9(3):e92153. doi: 10.1371/journal.pone.0092153. eCollection 2014.

14.

Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008.

Fielding JE, Grant KA, Papadakis G, Kelly HA.

BMC Infect Dis. 2011 Jun 14;11:170. doi: 10.1186/1471-2334-11-170.

15.

Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination.

Jiménez-Jorge S, de Mateo S, Delgado-Sanz C, Pozo F, Casas I, Garcia-Cenoz M, Castilla J, Pérez E, Gallardo V, Rodriguez C, Vega T, Quiñones C, Martínez E, Vanrell JM, Giménez J, Castrillejo D, Serrano Mdel C, Ramos JM, Larrauri A; Spanish Influenza Sentinel Surveillance System.

BMC Infect Dis. 2013 Sep 22;13:441. doi: 10.1186/1471-2334-13-441.

16.

Influenza vaccine effectiveness among elderly persons living in the community during the 2003--2004 season.

Hara M, Sakamoto T, Tanaka K.

Vaccine. 2008 Nov 25;26(50):6477-80. doi: 10.1016/j.vaccine.2008.06.035. Epub 2008 Jun 23.

PMID:
18573296
17.

Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis.

Castilla J, Martinez-Baz I, Martinez-Artola V, Fernandez-Alonso M, Reina G, Guevara M, Garcia Cenoz M, Elia F, Alvarez N, Barricarte A, Ezpeleta C.

Euro Surveill. 2013 Feb 14;18(7):2.

18.

Relationship of influenza vaccine match and use rate to medically attended acute respiratory illnesses in older residents of Maryland. November 13, 2012.

King JC Jr, Lichenstein R, Magder LS.

Vaccine. 2013 Jan 21;31(5):839-44. doi: 10.1016/j.vaccine.2012.11.054. Epub 2012 Dec 4.

PMID:
23219798
19.

Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: test-negative case-control studies using surveillance data, Spain, 2003-2011.

Savulescu C, Jiménez-Jorge S, Delgado-Sanz C, de Mateo S, Pozo F, Casas I, Larrauri A; Spanish Influenza Surveillance System.

Vaccine. 2014 Jul 31;32(35):4404-11. doi: 10.1016/j.vaccine.2014.06.063. Epub 2014 Jun 23.

PMID:
24968153
20.

Application of the screening method to monitor influenza vaccine effectiveness among the elderly in Germany.

Remschmidt C, Rieck T, Bödeker B, Wichmann O.

BMC Infect Dis. 2015 Mar 20;15:137. doi: 10.1186/s12879-015-0882-3.

Supplemental Content

Support Center